Tienan Yi
Xiangyang Central Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tienan Yi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05866354 · To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid MalignanciesZai Lab (Shanghai) Co., Ltd. · completed · Solid Malignancies · principal investigator
- N/ANCT04871997 · A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)Qian Chu · completed · NSCLC · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:58 UTC. The ranking covers the 200 most relevant of 93 PubMed records, and a shared surname and initials can bring in a namesake. All 93 on PubMed
- 543 citationsRCR 25.1
- Cardiovascular Safety of Testosterone-Replacement Therapy.N Engl J Med · 2023367 citationsRCR 48.7
- 354 citationsRCR 11.0
- Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.J Clin Oncol · 2022291 citationsRCR 18.2
- 208 citationsRCR 20.3
- Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.J Eur Acad Dermatol Venereol · 2018150 citationsRCR 5.8
- Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med · 2024145 citationsRCR 14.6
- Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.Nat Med · 2024134 citationsRCR 14.2
- The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.J Am Acad Dermatol · 2016122 citationsRCR 3.9
- Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.Vaccine · 200889 citationsRCR 2.4